Sugi Predict

Sugi Predict / Compounds / SCHEMBL10115544

SCHEMBL10115544

SCHEMBL10115544

CC(C)(C)S(=O)(=O)NC1CCN(C(=O)Nc2c(F)cc(F)cc2F)CC1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.40
▸ USP2 O75604 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ EPHX2 P34913 1/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ NPY5R Q15761 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ DPP4 P27487 5/20 0.37
▸ KCNH2 Q12809 4/20 0.37
▸ DPP7 Q9UHL4 3/20 0.37
▸ DPP8 Q6V1X1 3/20 0.37
▸ DPP9 Q86TI2 3/20 0.37
▸ PAK1 Q13153 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10115709 0.88 ALDH1A1 (0.45) OPRM1KMT2ANPY5RLMNANPSR1
SCHEMBL10115707 0.87 USP2 (0.47) USP2TSHRKMT2ALMNANPSR1
SCHEMBL10115708 0.85 OPRM1 (0.57) OPRM1KMT2ALMNAPAK1
SCHEMBL10115878 0.83 GRIA4 (0.40) OPRM1USP2TSHREPHX2KMT2A
SCHEMBL10114621 0.82 KMT2A (0.59) USP2TSHRKMT2ALMNANPSR1
SCHEMBL10115710 0.81 LMNA (0.46) USP2TSHREPHX2KMT2ALMNA
SCHEMBL10114313 0.81 NPY5R (0.55) TSHREPHX2KMT2ANPY5RNPC1
SCHEMBL10133224 0.81 NPY5R (0.55) TSHREPHX2KMT2ANPY5RNPC1
SCHEMBL10115586 0.81 NPC1 (0.58) USP2TSHREPHX2KMT2ALMNA
SCHEMBL10115734 0.81 USP2 (0.42) USP2TSHREPHX2KMT2ANPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R OPRM1 221/4885USP2 3137/4885TSHR 163/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R OPRM1 217/4885USP2 3680/4885TSHR 189/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R OPRM1 222/4885USP2 3174/4885TSHR 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.